- Inhibitors
- Antibodies
- Compound Libraries
- New Products
- Contact Us
research use only
Cat.No.S5400
| Related Targets | K-Ras CXCR Hedgehog/Smoothened PKA Adrenergic Receptor AChR 5-HT Receptor Histamine Receptor Dopamine Receptor Ras |
|---|---|
| Other GPR Products | ONC212 Fasiglifam(TAK-875) Hemihydrate GW9508 AH7614 JMS-17-2 AZD1981 GSK1292263 6-OAU GSK137647A TC-O 9311 |
|
In vitro |
DMSO
: 34 mg/mL
(197.02 mM)
Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 172.57 | Formula | C7H5ClO3 |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 53984-36-4 | -- | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | C1=C(C=C(C=C1O)Cl)C(=O)O | ||
| In vitro |
3-Chloro-5-hydroxybenzoic acid shows potency against human (EC50=16 μM), monkey (EC50=17 μM), dog (EC50=67 μM), rat (EC50=7 μM), mouse (EC50=22 μM), and hamster GPR81 (EC50=27 μM). |
|---|---|
| In vivo |
3-Chloro-5-hydroxybenzoic acid (30 mg/kg, 100 mg/kg, 300 mg/kg) shows significant reductions in free fatty acids, resulting in a minimum efficacious dose of 30 mg/kg. |
References |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.